,

Johannes Holle1, Rosa Reitmeir2, Felix Behrens2

  • 1Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany; Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; Department of General Pediatrics and Hematology/Oncology, University Children's Hospital, University Hospital Tübingen, Tübingen, Germany.

概括

肠道微生物组的变化之前的移植排斥,减少多样性和短链脂肪酸生产者在事件之前观察到. 这些变化可以作为移植接受者早期干预的生物标志物.